Rocket One Inc. Common Stock (NASDAQ:RKTO) Rating Lowered to Strong Sell at Wall Street Zen

Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Sunday.

Separately, Weiss Ratings downgraded shares of Rocket One Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Rocket One Inc. Common Stock presently has an average rating of “Hold” and an average price target of $5.00.

Get Rocket One Inc. Common Stock alerts:

Check Out Our Latest Stock Report on RKTO

Rocket One Inc. Common Stock Stock Performance

Shares of NASDAQ RKTO opened at $0.77 on Friday. The business has a 50 day simple moving average of $0.91 and a 200 day simple moving average of $0.91. Rocket One Inc. Common Stock has a 52 week low of $0.49 and a 52 week high of $2.45. The stock has a market cap of $17.10 million, a price-to-earnings ratio of -0.93 and a beta of 0.96.

Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.19) earnings per share for the quarter.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of RKTO. Lido Advisors LLC bought a new position in Rocket One Inc. Common Stock in the 3rd quarter worth $32,000. Kestra Private Wealth Services LLC bought a new stake in Rocket One Inc. Common Stock during the third quarter valued at about $51,000. Virtu Financial LLC bought a new stake in Rocket One Inc. Common Stock during the third quarter valued at about $184,000. Geode Capital Management LLC grew its position in shares of Rocket One Inc. Common Stock by 8.0% in the second quarter. Geode Capital Management LLC now owns 122,575 shares of the company’s stock valued at $143,000 after purchasing an additional 9,071 shares during the last quarter. Finally, Citadel Advisors LLC acquired a new stake in shares of Rocket One Inc. Common Stock in the third quarter valued at about $232,000. 7.08% of the stock is currently owned by institutional investors and hedge funds.

About Rocket One Inc. Common Stock

(Get Free Report)

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.

Further Reading

• Five stocks we like better than Rocket One Inc. Common Stock
• Commodities Are Booming, But These 3 ETFs Tell Different Stories
• 3 Active ETFs Making Big Moves in August
• This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
• Birkenstock Beats the Skeptics—But Not on EPS

Receive News & Ratings for Rocket One Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket One Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.